Rare Skin Cancers

Rare skin tumours can be difficult to identify in their early stages, making early detection essential for effective treatment. At the Grupo Pedro Jaén Skin Cancer Unit, advanced diagnostic tools such as confocal microscopy, digital dermoscopy and the Vectra 360 system are used to identify suspicious lesions with a high level of accuracy.

Importance of early diagnosis

Detection of rare skin cancers at early stages improves clinical outcomes and allows for more conservative, less invasive treatments. Early diagnosis limits tumour progression, reduces the risk of complications and supports appropriate treatment selection.

Technology for complex cases

Less common skin cancers present specific diagnostic challenges. Advanced imaging techniques and dedicated diagnostic protocols allow differentiation between malignant tumours and benign skin lesions, reducing unnecessary procedures and supporting accurate clinical decision-making.

The treatment of rare skin cancers requires a coordinated and highly specialised approach. At Grupo Pedro Jaén, care is provided by a multidisciplinary team including dermatologists, surgeons, oncologists and radiologists, who work together to define the optimal treatment strategy for each patient.

Experience in aggressive tumours

The unit has specific experience in managing rare tumours such as Kaposi’s sarcoma, Merkel cell carcinoma and sebaceous carcinoma. These tumours may progress rapidly or present with non-specific clinical features, requiring a high level of expertise in diagnosis and treatment.

Coordination with other specialist units

Close collaboration with medical oncology and radiation oncology teams allows a comprehensive approach to care. Depending on tumour characteristics and patient factors, surgery, radiotherapy and systemic therapies may be combined to tailor treatment to disease evolution and individual needs.

Management of rare skin cancers aims not only to achieve complete tumour removal, but also to preserve skin function and appearance, particularly in sensitive areas such as the face, eyelids or scalp. Advanced surgical techniques are applied to minimise functional and aesthetic impact.

Minimally invasive surgery

The unit includes specialists in dermatological surgery who perform techniques such as Mohs surgery, which allows precise tumour removal while preserving as much healthy tissue as possible. This approach is especially important in areas where surgical margins must be limited.

Aesthetic and functional reconstruction

When treatment involves visible areas, collaboration with plastic surgeons and reconstructive ophthalmologists supports restoration of facial balance and skin function. This multidisciplinary approach contributes to optimal healing and aesthetic outcomes.

Management of rare skin tumours extends beyond initial treatment and requires long-term follow-up to detect recurrence and identify new lesions at early stages. Personalised follow-up plans are designed for each patient, including regular check-ups and preventive measures.

Therapeutic options for rare tumours

Depending on tumour type, location and extent, treatment may involve surgery, immunotherapy and radiotherapy. Participation in clinical research and the application of innovative therapies allow access to evolving treatment options aimed at improving disease control and patient outcomes.

Advanced technology for dermatological monitoring

Regular follow-up includes digital tools such as the Vectra 360 system, which enables three-dimensional mapping of skin lesions and comparison of subtle changes over time. Confocal microscopy is used to evaluate suspicious lesions non-invasively, supporting real-time diagnostic assessment.